Navigation Links
Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.

Legacy of Regulatory Submissions Leadership Strengthened with Clinical

Trials Services and Standards-Based Data Management

WHIPPANY, N.J. and ATLANTA, Sept. 6 /PRNewswire/ -- Image Solutions, Inc. (ISI) announced today it agreed to terms to acquire Zurich Biostatistics, Inc. (ZBI). With the Life Sciences industry moving to standards-based regulatory submissions, the acquisition further strengthens ISI's Clinical Data Interchange Standards Consortium (CDISC) capabilities, the FDA-supported standard for clinical trials data and metadata.

"The FDA's embrace of CDISC standards presents pharma and biotech companies with a once-in-a-decade opportunity to streamline processes and harmonize operations with submissions," said Jinsoo Kim, ISI president and chief executive officer. "Our portfolio of clinical trials services gains instant experience and credential with the acquisition of ZBI."

ZBI and its president, Michael Palmer, pioneered the development and implementation of CDISC-based regulatory submissions. Palmer has co-authored and contributed to CDISC standards since 2000. He will continue at ISI as vice president of biometrics, overseeing the company's CDISC products and services.

"Over the next year, the FDA will rapidly move towards data standardization as a way to expedite innovation and bring new drugs to market faster and more effectively, an issue the industry is finding much more difficult then it was five years ago," said Palmer. "The health and well-being of millions of people is at stake -- the streamlining of drug development has never been more important."

ISI's acquisition of ZBI also bolsters the company's new biometrics' service line. Securing FDA approval on new drug submissions frequently hinges on the analyses of biometrics data. With clinical trials costing drug sponsors hundreds of millions of dollars, failed submissions can be detrimental. By adding highly qualified and experienced statisticians and programmers, ISI is able to help clients create statistical plans, conduct analyses and assist in the preparation of reports to avoid these pitfalls. Companies are also able to achieve more effective collaboration between statisticians and medical writers, speeding time to final CSR.

ZBI's core capabilities in biometrics analysis support ISI's commitment to complete, holistic regulatory submissions. Existing clients of both ISI and ZBI now have instant access to this approach and capability.

ISI is a pioneer in modernizing the regulatory submission process. The company enabled the first-ever electronic new drug application to the FDA and is at the forefront of the industry's move to adopting the electronic Common Technical Document (eCTD), the new drug application standard that will be required by the FDA at the end of 2007.

About Image Solutions, Inc.

Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered more than 1,000 electronic submissions and 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations. For more information, visit the company Web site at

Press Contacts:

Lisa Meyer Kurt Rossler

Director, Global Marketing M Booth & Associates

973-560-0808 x. 217 212 481-7000

SOURCE Image Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology news :

1. Image of myosin-actin interaction revealed in cover story of Molecular Cell
2. Key heart and Alzheimers disease protein imaged for first time in native state
3. New MRI technique quickly builds 3-D images of knees
4. Everything in its place: Researchers identify brain cells used to categorize images
5. With record resolution and sensitivity, tool images how life organizes in a cell membrane
6. Researchers image molecular motor structural changes
7. Detailed 3-D image catches a key regulator of neural stem cell differentiation in action
8. CSIRO imagery shows Outer Great Barrier Reef at risk from river plumes
9. Novel computed imaging technique uses blurry images to enhance view
10. Ultrasound upgrade produces images that work like 3-D movies
11. Researchers wake up viruses inside tumors to image and then destroy cancers
Post Your Comments:
(Date:11/4/2015)... , November 4, 2015 ... new market report published by Transparency Market Research "Home Security ... Trends and Forecast 2015 - 2022", the global home security ... 30.3 bn by 2022. The market is estimated to ... period from 2015 to 2022. Rising security needs among ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
(Date:10/27/2015)... 2015 Munich, Germany ... technology (ASGM) automatically maps data from mobile eye tracking ... , so that they can be quantitatively analyzed with ... Munich, Germany , October 28-29, 2015. SMI,s Automated ... mobile eye tracking videos created with SMI,s Eye ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh ... Insertion points for in-line sensors can represent a weak spot where leaking process ... series of retractable sensor housings , which are designed to tolerate extreme process ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list of ... OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic ...
(Date:11/24/2015)... 2015 Capricor Therapeutics, Inc. (NASDAQ: ... discovery, development and commercialization of first-in-class therapeutics, today announced ... is scheduled to present at the 2015 Piper Jaffray ... EST, at The Lotte New York Palace Hotel in ... . --> . ...
Breaking Biology Technology: